AACC Calls on Congress to Cut VALID Act from New Legislation
AACC has urged the U.S. Senate HELP Committee not to include the VALID Act in its omnibus Food and Drug Administration user fee legislation.
Read MorePosted by Andy Lundin | May 25, 2022 | Miscellaneous |
AACC has urged the U.S. Senate HELP Committee not to include the VALID Act in its omnibus Food and Drug Administration user fee legislation.
Read MorePosted by Andy Lundin | May 24, 2022 | Covid 19 |
The majority (75.8%) of patients diagnosed with a post-COVID condition, also known as long COVID, had never been hospitalized for COVID-19.
Read MorePosted by Andy Lundin | May 23, 2022 | Covid 19, Immunoassay Reagents & test Kits |
LumiraDx’s rapid COVID-19 antigen assay, LumiraDx SARS-CoV-2 Ag Test received the Emergency Use Listing by the World Health Organization.
Read MorePosted by Chris Wolski | May 20, 2022 | Covid 19, Emerging & Zoonotic Diseases |
A clear set of pandemic prevention and preparedness strategies will be critical for clinical labs to meet the challenges the next event.
Read MorePosted by Andy Lundin | May 20, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Next-generation point-of-care diagnostics company LumiraDx announced that its quick SARS-CoV-2 Ag Ultra Test achieved CE Marking.
Read More